Assessment of Routine Oral Screening Programs for New Prisoners
DepiDent
1 other identifier
observational
1,000
1 country
1
Brief Summary
In 2018, 10 detention centers in France will start organisational programs to improve the quality of screening of oral diseases, relatively to French recommendations, among new prisoners in France. Our study aims 1) to assess the prevalence and nosology of oral diseases ; 2) to describe the care pathway of participants during their stay in the detention center where they were included ; 3) to assess the cost of care per patient, from a societal perspective, using a top-down method.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Mar 2018
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 1, 2018
CompletedStudy Start
First participant enrolled
March 1, 2018
CompletedFirst Posted
Study publicly available on registry
November 8, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2021
CompletedJune 5, 2020
June 1, 2020
3.2 years
February 1, 2018
June 4, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
Description of the oral problems of people entering detention
Description of the oral problems of people entering detention : Any oral disease at inclusion (prevalence study)
1 day
Secondary Outcomes (1)
attending to consultations
The collection of data will end at the discharge of the participant, or at 6 months after inclusion.
Eligibility Criteria
New prisoners
You may qualify if:
- new prisoners
- fluent French language
You may not qualify if:
- adult guardianship
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University Hospital, Montpellierlead
- General Health Office, Francecollaborator
Study Sites (1)
Uhmontpellier
Montpellier, 34295, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Claire M DUFLOS
University Hospital, Montpellier
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 1, 2018
First Posted
November 8, 2018
Study Start
March 1, 2018
Primary Completion
May 1, 2021
Study Completion
December 1, 2021
Last Updated
June 5, 2020
Record last verified: 2020-06